Published in Women's Health Law Weekly, August 14th, 2005
"After failure of anthracycline-and taxane-based chemotherapy in metastatic breast cancer, treatment options until recently were limited. Until the introduction of capecitabine and vinorelbine, no standard regimen was available," scientists writing in the journal Clinical Oncology report.
According to M.P. Decatris, and colleagues, Bank of Cyprus Oncology Center, "We conducted a retrospective study to determine the efficacy and toxicity of platinum-based chemotherapy in metastatic breast cancer. Forty-two women with metastatic breast cancer previously treated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly